Data on Pneumococcal Disease Vaccine Trial Presented at International Symposium
ImmunoBiology recently reported positive data from its first in human clinical trial (NCT02572635) on PnuBioVax, a vaccine targeting pneumococcal disease that utilizes the company’s ImmBioVax technology. Streptococcus pneumoniae is a type of bacteria that can ... Read more